Organon chemist Anton Bom had the radical idea of making a drug that targets another drug, rather than targeting a protein, as just about every other drug on the market does.
By leveraging Newport Media's advanced OFDM baseband and RF CMOS technology, the NMC1000 offers levels of performance, power consumption, and external bill of material (BOM) typically associated with the world's leading connectivity solutions providers.